• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植入式心脏复律除颤器患者的临床经验。

Clinical experience in patients with implantable cardioverter defibrillators.

作者信息

Tsuji H, Shahian D M, Venditti F J

机构信息

Section of Cardiology, Lahey Clinic Medical Center, Burlington, Massachusetts.

出版信息

Jpn Circ J. 1991 Jul;55(7):669-75. doi: 10.1253/jcj.55.669.

DOI:10.1253/jcj.55.669
PMID:1880899
Abstract

Forty patients (36 men and 4 women) with life-threatening arrhythmia received an implantable cardioverter defibrillator (ICD). Mean age was 63 years (range, 46 to 80 years). All patients had structural heart disease, with coronary artery disease in 32 patients, idiopathic cardiomyopathy in 7 patients, and hypertensive heart disease in 1 patient. Mean left ventricular ejection fraction was 29 +/- 13%. The clinical arrhythmia was out-of-hospital cardiac arrest in 14 patients (35%), symptomatic sustained ventricular tachycardia in 21 patients (53%), and episodes of syncope without documented spontaneous ventricular arrhythmia but ventricular tachycardia that was easily provoked at the time of electrophysiologic testing in 5 patients (13%). Sustained ventricular tachycardia was induced in 37 patients (93%) at basic electrophysiologic testing. The average number of drug failures was 2.9 +/- 1.4 per patient. One patient (2.5%) died perioperatively because of intractable ventricular tachycardia and ventricular fibrillation. During a median follow-up period of 5.5 months (range 2-21 months) 2 sudden deaths occurred. No patient had a serious complication during the follow-up period. Ten patients (25%) received antiarrhythmic drugs to suppress spontaneous ventricular tachycardia. Appropriate shock treatment was received by 18 patients (45%), and inappropriate shock treatment was received by 2 patients (5%). Several issues regarding use of the ICD must be considered, but the device seems to be useful, and it is associated with an acceptable rate of complications and good long-term success at the present time.

摘要

40例有危及生命心律失常的患者(36例男性,4例女性)接受了植入式心脏复律除颤器(ICD)治疗。平均年龄63岁(范围46至80岁)。所有患者均有结构性心脏病,其中32例患有冠状动脉疾病,7例患有特发性心肌病,1例患有高血压性心脏病。平均左心室射血分数为29±13%。临床心律失常情况为:14例患者(35%)发生院外心脏骤停,21例患者(53%)出现有症状的持续性室性心动过速,5例患者(13%)出现无记录的自发性室性心律失常但在电生理检查时容易诱发室性心动过速的晕厥发作。在基础电生理检查中,37例患者(93%)诱发出持续性室性心动过速。每位患者平均药物治疗失败次数为2.9±1.4次。1例患者(2.5%)围手术期因顽固性室性心动过速和心室颤动死亡。在中位随访期5.5个月(范围2至21个月)内发生了2例猝死。随访期间无患者出现严重并发症。10例患者(25%)接受抗心律失常药物以抑制自发性室性心动过速。18例患者(45%)接受了适当的电击治疗,2例患者(5%)接受了不适当的电击治疗。关于ICD的使用必须考虑几个问题,但目前该装置似乎是有用的,并且其并发症发生率可接受,长期成功率良好。

相似文献

1
Clinical experience in patients with implantable cardioverter defibrillators.植入式心脏复律除颤器患者的临床经验。
Jpn Circ J. 1991 Jul;55(7):669-75. doi: 10.1253/jcj.55.669.
2
Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.使用带有三电极系统的植入式心脏复律除颤器进行心内膜除颤的初步临床经验。
Arch Intern Med. 1989 Oct;149(10):2333-9.
3
Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.新型植入式起搏除颤器所提供的自动多模式设备治疗室性快速心律失常的疗效。一项欧洲多中心研究(涉及102例植入)的结果
Circulation. 1992 Aug;86(2):363-74. doi: 10.1161/01.cir.86.2.363.
4
Effect of antiarrhythmic drug therapy on the incidence of shocks in patients who receive an implantable cardioverter defibrillator after a single episode of sustained ventricular tachycardia/fibrillation.抗心律失常药物治疗对单次持续性室性心动过速/心室颤动发作后接受植入式心脏复律除颤器患者电击发生率的影响。
Pacing Clin Electrophysiol. 1991 Nov;14(11 Pt 1):1586-92. doi: 10.1111/j.1540-8159.1991.tb02733.x.
5
Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group.第二代植入式心脏起搏器除颤器用于恶性室性心律失常患者的长期多中心经验。监护仪多中心研究组。
J Am Coll Cardiol. 1992 Mar 1;19(3):490-9. doi: 10.1016/s0735-1097(10)80260-8.
6
Clinical experience in seventy-seven patients with the automatic implantable cardioverter defibrillator.77例植入式自动心脏复律除颤器患者的临床经验。
Am Heart J. 1989 Sep;118(3):445-50. doi: 10.1016/0002-8703(89)90256-1.
7
Long-term outcome with the automatic implantable cardioverter-defibrillator.
J Am Coll Cardiol. 1989 May;13(6):1353-61. doi: 10.1016/0735-1097(89)90310-0.
8
Usefulness of the automatic implantable cardioverter defibrillator in improving survival of patients with severely depressed left ventricular function associated with coronary artery disease.植入式自动心脏复律除颤器对改善伴有冠状动脉疾病的严重左心室功能不全患者生存率的作用。
Am J Cardiol. 1991 Apr 15;67(9):812-6. doi: 10.1016/0002-9149(91)90612-o.
9
Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy.
J Am Coll Cardiol. 1991 Jul;18(1):145-51. doi: 10.1016/s0735-1097(10)80232-3.
10
Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.多非利特可降低室性心律失常和植入式心脏复律除颤器治疗的频率。
J Cardiovasc Electrophysiol. 2012 Mar;23(3):296-301. doi: 10.1111/j.1540-8167.2011.02183.x. Epub 2011 Sep 28.